Alexandra Kegler

856 total citations
23 papers, 612 citations indexed

About

Alexandra Kegler is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Alexandra Kegler has authored 23 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Immunology and 10 papers in Biomedical Engineering. Recurrent topics in Alexandra Kegler's work include CAR-T cell therapy research (20 papers), Nanowire Synthesis and Applications (9 papers) and Immunotherapy and Immune Responses (7 papers). Alexandra Kegler is often cited by papers focused on CAR-T cell therapy research (20 papers), Nanowire Synthesis and Applications (9 papers) and Immunotherapy and Immune Responses (7 papers). Alexandra Kegler collaborates with scholars based in Germany, Hungary and Colombia. Alexandra Kegler's co-authors include Anja Feldmann, Michael Bachmann, Claudia Arndt, Ralf Bergmann, Stefanie Koristka, Gerhard Ehninger, Jens Pietzsch, Marc Cartellieri, Armin Ehninger and Marc Schmitz and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Alexandra Kegler

23 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandra Kegler Germany 14 494 273 216 181 107 23 612
Nicole Berndt Germany 17 461 0.9× 204 0.7× 367 1.7× 275 1.5× 89 0.8× 34 798
S. Y. Jennifer United States 10 561 1.1× 339 1.2× 250 1.2× 292 1.6× 155 1.4× 12 763
Andrew J. Hou United States 6 637 1.3× 240 0.9× 294 1.4× 223 1.2× 134 1.3× 7 753
Ryan D. Guest United Kingdom 7 636 1.3× 262 1.0× 268 1.2× 162 0.9× 162 1.5× 11 672
Eugenia Zah United States 4 659 1.3× 269 1.0× 211 1.0× 231 1.3× 176 1.6× 5 700
Angela C. Boroughs United States 8 641 1.3× 245 0.9× 321 1.5× 264 1.5× 203 1.9× 8 812
Elisa Landoni United States 12 625 1.3× 253 0.9× 300 1.4× 236 1.3× 173 1.6× 14 762
Simon Loff Germany 8 494 1.0× 251 0.9× 152 0.7× 164 0.9× 149 1.4× 13 537
Stefanie Lesch Germany 8 686 1.4× 211 0.8× 278 1.3× 284 1.6× 188 1.8× 10 798
Mohamed-Reda Benmebarek Germany 9 594 1.2× 190 0.7× 259 1.2× 213 1.2× 148 1.4× 17 686

Countries citing papers authored by Alexandra Kegler

Since Specialization
Citations

This map shows the geographic impact of Alexandra Kegler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandra Kegler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandra Kegler more than expected).

Fields of papers citing papers by Alexandra Kegler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandra Kegler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandra Kegler. The network helps show where Alexandra Kegler may publish in the future.

Co-authorship network of co-authors of Alexandra Kegler

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandra Kegler. A scholar is included among the top collaborators of Alexandra Kegler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandra Kegler. Alexandra Kegler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitwasi, Nicola, Liliana R. Loureiro, Alexandra Kegler, et al.. (2024). RevCAR-expressing immune effector cells for targeting of Fn14-positive glioblastoma. Cancer Gene Therapy. 31(9). 1323–1334. 1 indexed citations
2.
Mitwasi, Nicola, Martin Ullrich, Manja Kubeil, et al.. (2023). Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells. Frontiers in Immunology. 14. 1166169–1166169. 9 indexed citations
3.
Mata, Eduardo Sergio Oliveros, Markus Laube, Anja Feldmann, et al.. (2023). Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies. ACS Sensors. 8(2). 576–586. 29 indexed citations
4.
Loureiro, Liliana R., Christin Neuber, Claudia Arndt, et al.. (2023). Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment. Journal of Experimental & Clinical Cancer Research. 42(1). 341–341. 17 indexed citations
5.
Loureiro, Liliana R., Claudia Arndt, Alexandra Kegler, et al.. (2023). Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells. Frontiers in Immunology. 14. 1302354–1302354. 8 indexed citations
6.
Lindner, Diana, Claudia Arndt, Liliana R. Loureiro, et al.. (2022). Combining Radiation- with Immunotherapy in Prostate Cancer: Influence of Radiation on T Cells. International Journal of Molecular Sciences. 23(14). 7922–7922. 3 indexed citations
7.
Mitwasi, Nicola, Claudia Arndt, Liliana R. Loureiro, et al.. (2022). Targeting CD10 on B-Cell Leukemia Using the Universal CAR T-Cell Platform (UniCAR). International Journal of Molecular Sciences. 23(9). 4920–4920. 4 indexed citations
8.
Arndt, Claudia, Liliana R. Loureiro, Alexandra Kegler, et al.. (2021). A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity. International Journal of Molecular Sciences. 22(21). 12046–12046. 2 indexed citations
9.
Loureiro, Liliana R., Anja Hoffmann, Ralf Bergmann, et al.. (2021). Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy. Cancers. 13(19). 4785–4785. 27 indexed citations
10.
Berndt, Nicole, Claudia C. Bippes, Irene Michalk, et al.. (2021). And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling. International Journal of Molecular Sciences. 22(18). 9699–9699. 10 indexed citations
11.
Bachmann, Michael, Claudia C. Bippes, Holger Bartsch, et al.. (2021). T Cell Mediated Conversion of a Non-Anti-La Reactive B Cell to an Autoreactive Anti-La B Cell by Somatic Hypermutation. International Journal of Molecular Sciences. 22(3). 1198–1198. 7 indexed citations
12.
Feldmann, Anja, Ralf Bergmann, Claudia Arndt, et al.. (2020). <p>Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab<sup>®</sup></p>. OncoTargets and Therapy. Volume 13. 5515–5527. 18 indexed citations
13.
Koristka, Stefanie, Ralf Bergmann, Claudia Arndt, et al.. (2019). Anti-CAR-engineered T cells for epitope-based elimination of autologous CAR T cells. Cancer Immunology Immunotherapy. 68(9). 1401–1415. 26 indexed citations
14.
Bergmann, Ralf, Nicole Berndt, Stefanie Koristka, et al.. (2019). An oligo-His-tag of a targeting module does not influence its biodistribution and the retargeting capabilities of UniCAR T cells. Scientific Reports. 9(1). 10547–10547. 15 indexed citations
15.
Koristka, Stefanie, Alexandra Kegler, Ralf Bergmann, et al.. (2018). Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology. Journal of Autoimmunity. 90. 116–131. 62 indexed citations
16.
Mitwasi, Nicola, Anja Feldmann, Ralf Bergmann, et al.. (2017). Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells. Oncotarget. 8(65). 108584–108603. 47 indexed citations
17.
Feldmann, Anja, Claudia Arndt, Ralf Bergmann, et al.. (2017). Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”. Oncotarget. 8(19). 31368–31385. 96 indexed citations
18.
Albert, Susann, Claudia Arndt, Anja Feldmann, et al.. (2017). A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform. OncoImmunology. 6(4). e1287246–e1287246. 88 indexed citations
19.
Bergmann, Ralf, Anja Feldmann, Stefanie Koristka, et al.. (2017). Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells. Oncotarget. 9(7). 7487–7500. 40 indexed citations
20.
Froschauer, Alexander, et al.. (2015). Tunable Protein Stabilization In Vivo Mediated by Shield-1 in Transgenic Medaka. PLoS ONE. 10(7). e0131252–e0131252. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Berndt Breakdown of academic impact, for papers by S. Y. Jennifer Breakdown of academic impact, for papers by Andrew J. Hou Breakdown of academic impact, for papers by Ryan D. Guest Breakdown of academic impact, for papers by Eugenia Zah Breakdown of academic impact, for papers by Angela C. Boroughs Breakdown of academic impact, for papers by Elisa Landoni Breakdown of academic impact, for papers by Simon Loff Breakdown of academic impact, for papers by Stefanie Lesch Breakdown of academic impact, for papers by Mohamed-Reda Benmebarek
Rankless by CCL
2026